To include your compound in the COVID-19 Resource Center, submit it here.

CDER seeks to limit scope of Avastin hearing

FDA's Center for Drug Evaluation and Research said it does not believe future studies of Avastin bevacizumab are

Read the full 189 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE